Subscribe To
Investor alert: abbott cooper pllc announces investigation into zentalis pharmaceuticals, inc.; urges zentalis stockholders to contact abbott cooper regarding their legal rights
STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” ...
November 4, 2023, 3:53 pm
Actinium pharmaceuticals: the trickle down continues, and i maintain a buy
Actinium pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, whi...
November 3, 2023, 6:08 pm
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Quoin pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Comp...
November 3, 2023, 12:41 pm
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Quoin pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Compa...
November 3, 2023, 8:41 am
Acadia pharmaceuticals inc. (acad) q3 2023 earnings call transcript
ACADIA pharmaceuticals Inc. (NASDAQ:ACAD ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET...
November 3, 2023, 3:54 am
Apellis alert: bragar eagel & squire, p.c. is investigating apellis pharmaceuticals, inc. on behalf of long-term stockholders and encourages investors to contact the firm
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
November 3, 2023, 1:00 am
Syndax pharmaceuticals inc (sndx) q3 2023 earnings call transcript
Syndax pharmaceuticals Inc (SNDX) Q3 2023 Earnings Call Transcript...
November 2, 2023, 9:26 pm
Ngm biopharmaceuticals (ngm) reports q3 loss, misses revenue estimates
NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.35 per share versus the Zacks Consens...
November 2, 2023, 6:47 pm
Vertex pharmaceuticals (vrtx) rises higher than market: key facts
The latest trading day saw Vertex pharmaceuticals (VRTX) settling at $376.55, representing a +1.95% cha...
November 2, 2023, 6:47 pm
Ionis pharmaceuticals, inc. (ions) q3 2023 earnings call transcript
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS ) Q3 2023 Earnings Conference Call November 2, 2023 11:30 AM ET Company Participants Wade Walke - Senior Vice...
November 2, 2023, 5:20 pm
Aurinia pharmaceuticals inc. (auph) q3 2023 earnings call transcript
Aurinia pharmaceuticals Inc. (NASDAQ:AUPH ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM E...
November 2, 2023, 12:06 pm
Gsk falls victim of ‘hard to please' pharma market
GSK PLC (LSE:GSK, NYSE:GSK)'s seemingly positive earnings release on Wednesday has been labelled as just that by Stifel analysts, who were left mullin...
November 2, 2023, 11:02 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...
November 2, 2023, 9:15 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...
November 2, 2023, 9:05 am
Aurinia pharmaceuticals (auph) reports q3 loss, tops revenue estimates
Aurinia pharmaceuticals (AUPH) came out with a quarterly loss of $0.09 per share versus the Zacks Conse...
November 2, 2023, 8:16 am
Novabay pharmaceuticals to hold third quarter 2023 conference call on november 9, 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the thre...
November 2, 2023, 6:50 am
Regeneron pharma's adjusted earnings beat estimates
Regeneron pharmaceuticals Inc.'s stock REGN, +1.46% rose fractionally on Thursday after the drug maker ...
November 2, 2023, 6:49 am
Regeneron beats quarterly profit estimates on eczema treatment strength
Regeneron pharmaceuticals on Thursday beat Wall Street estimates for third-quarter profit, driven by st...
November 2, 2023, 6:42 am